Qube Research & Technologies LTD Opti Nose, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Opti Nose, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 148,551 shares of OPTN stock, worth $118,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
148,551Holding current value
$118,840% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding OPTN
# of Institutions
79Shares Held
85.2MCall Options Held
0Put Options Held
0-
Mvm Partners, LLC Boston, MA14.6MShares$11.7 Million15.07% of portfolio
-
Great Point Partners LLC Greenwich, CT13.7MShares$11 Million3.78% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT13.4MShares$10.7 Million0.93% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY5.6MShares$4.48 Million0.68% of portfolio
-
Black Rock Inc. New York, NY5.27MShares$4.22 Million0.0% of portfolio
About OptiNose, Inc.
- Ticker OPTN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 83,277,504
- Market Cap $66.6M
- Description
- OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...